510
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Efficacy and safety of cariprazine in the treatment of bipolar disorder

, &
Pages 2063-2072 | Received 25 Mar 2019, Accepted 22 Aug 2019, Published online: 23 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Danica E. Johnson, Roger S. McIntyre, Rodrigo B. Mansur & Joshua D. Rosenblat. (2023) An update on potential pharmacotherapies for cognitive impairment in bipolar disorder. Expert Opinion on Pharmacotherapy 24:5, pages 641-654.
Read now
Laura Orsolini, Domenico De Berardis & Umberto Volpe. (2020) Up-to-date expert opinion on the safety of recently developed antipsychotics. Expert Opinion on Drug Safety 19:8, pages 981-998.
Read now

Articles from other publishers (9)

Luyao Cai, Guanjie Chen, Haichen Yang & Yuanhan Bai. (2023) Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology 38:4, pages 249-260.
Crossref
Philip B. Mitchell. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry 1 31 .
Cristian-Daniel Llach, Anna Giménez-Palomo & Eduard Vieta. (2022) Uso de cariprazina en el trastorno bipolar: una revisión sistemática y aspectos prácticos. Psiquiatría Biológica 29:3, pages 100378.
Crossref
Sahithi Madireddy & Samskruthi Madireddy. (2022) Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder. International Journal of Molecular Sciences 23:3, pages 1844.
Crossref
André Do, Kamyar Keramatian, Ayal Schaffer & Lakshmi Yatham. (2021) Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials. Frontiers in Psychiatry 12.
Crossref
Ulrich W. Preuss, Martin Schaefer, Christoph Born & Heinz Grunze. (2021) Bipolar Disorder and Comorbid Use of Illicit Substances. Medicina 57:11, pages 1256.
Crossref
ShivaShanker Reddy Mukku, RaviKumar Nadella & SumanthEdiga Kornapalli. (2021) Cariprazine for late-life psychiatric illness: A review on therapeutic potential and challenges. Journal of Geriatric Mental Health 8:2, pages 77.
Crossref
Herbert Y. Meltzer & Erick Gadaleta. (2021) Contrasting Typical and Atypical Antipsychotic Drugs. FOCUS 19:1, pages 3-13.
Crossref
Lakshmi N. Yatham, Eduard Vieta & Willie Earley. (2020) Evaluation of cariprazine in the treatment of bipolar I and II depression. International Clinical Psychopharmacology 35:3, pages 147-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.